Wutah dodolan YoY sajrone 12 wulan kepungkur: turnstonebio.com (TSBX)

Turnstone Biologics relies on internal resources to advance solid tumor research, excluding external mergers. Scalability is driven by viral platforms that reduce costs when developing therapies for various types of cancer. The year-over-year sales growth rate for the trailing four quarters on this GURU.Markets chart shows that the parameter value is , confirming risk diversification through the synthesis of oncolytic viruses and cell therapy.
Turnstone Biologics (TSBX) - rincian metrik lan laporan keuangan

Investors are verifying the reliability of Turnstone Biologics (TSBX) by analyzing revenue expansion rates while excluding the impact of random market fluctuations. The rolling 12-month year-over-year sales growth rate smooths out inflationary noise, confirming real customer purchasing power and the stability of the company's sovereign product cycle, which transforms the asset into a defensive tool isolated from global macroeconomic shocks.